Tower Research Capital »

Mersana Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 1.6k 7.76

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics